Coronavirus Infections: all 952 studies
Page 5 of 10. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- Renal Involvement in Hospitalized Children With COVID-19CompletedNCT04788394
- COVID-19 Infections and Mortality in Long-term Care Facilities During the First WaveCompletedNCT04782427
- Increasing Vaccine Uptake in Underresourced Public Housing AreasCompletedNCT04779138Not applicable
- Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)Status unknownNCT04768998
- Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19CompletedNCT04765371Phase 3
- Persistence of Symptoms After Improvement of Acute COVID-19CompletedNCT04764773
- Couple HOPES and COVID-19CompletedNCT04763681Not applicable
- CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit DischargeCompletedNCT04762056
- A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.CompletedNCT04760990
- Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective CohortCompletedNCT04758039
- Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?CompletedNCT04757272
- Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2CompletedNCT04755972Not applicable
- Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus PandemicStatus unknownNCT04752839
- Annexin A5 in Patients With Severe COVID-19 DiseaseCompletedNCT04748757Phase 2
- COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) StudyTerminatedNCT04746430Phase 4
- Steam Inhalations in COVID-19 PatientsTerminatedNCT04743349Not applicable
- A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)CompletedNCT04742725Phase 2
- Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) InfectionCompletedNCT04739345Not applicable
- Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian PatientsCompletedNCT04738760
- Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19CompletedNCT04736901
- Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm SyndromeCompletedNCT04734678
- User Experience of the OSR M-1TerminatedNCT04733677
- Exploring Vaccine Confidence and Uptake of Potential COVID-19 VaccinesCompletedNCT04731870
- The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer PatientsWithdrawnNCT04731051Phase 1/2
- Evaluation of a Synbiotic Formula in Patient With COVID-19Status unknownNCT04730284Not applicable
- MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) SurveyStatus unknownNCT04727294
- Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress SyndromeCompletedNCT04725084
- Evolution of Coronavirus Disease 2019 (COVID-19) Patients in ExtremaduraCompletedNCT04724850
- Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the SalivaCompletedNCT04723446Not applicable
- A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther FusionCompletedNCT04720794Not applicable
- A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test KitCompletedNCT04720235Not applicable
- Migrant Workers' Responses to the COVID-19 PandemicCompletedNCT04718519
- TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 PatientsCompletedNCT04716556Not applicable
- Fluvoxamine for Adults With Mild to Moderate COVID-19SuspendedNCT04711863Phase 2
- Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)CompletedNCT04710199Phase 2
- Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI)CompletedNCT04709003
- Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of RouenTerminatedNCT04707833Not applicable
- Antiviral T Lymphocyte Immunity During Acute COVID-19 InfectionCompletedNCT04707820Not applicable
- Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisTerminatedNCT04707703Phase 3
- Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for RehabilitationCompletedNCT04695301Not applicable
- Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 ProteinsCompletedNCT04690920Not applicable
- Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 PatientsCompletedNCT04686760Not applicable
- Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGenCompletedNCT04684615
- Role of Mega Dose of Vitamin C in Critical COVID-19 PatientsCompletedNCT04682574Not applicable
- Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk IndividualsCompletedNCT04681430Phase 2
- Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistanceStatus unknownNCT04678700Not applicable
- Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 PatientsWithdrawnNCT04674410
- Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in ArgentinaCompletedNCT04673279
- Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized PatientsTerminatedNCT04672564Phase 3
- Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR)CompletedNCT04668196
- Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2CompletedNCT04665960
- Oral Isotretinoin and Covid-19 InfectionCompletedNCT04663906
- Adolescents With COVID-19/MIS-C at HCFMUSPStatus unknownNCT04659486Not applicable
- RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot StudyStatus unknownNCT04659460Not applicable
- NOSOcomial COVID-19 in ICU (NOSOCOVID)Status unknownNCT04659356
- ASCO Survey on COVID-19 in Oncology (ASCO) RegistryActive, not recruitingNCT04659135
- Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score StudyCompletedNCT04657471Not applicable
- Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household ContactsCompletedNCT04652648Phase 4
- Surfactant Protein Genetic Variants in COVID-19 InfectionCompletedNCT04650191
- Efficacy and Safety of TY027, a Treatment for COVID-19, in HumansTerminatedNCT04649515Phase 3
- Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy PopulationCompletedNCT04649021Phase 2
- Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)CompletedNCT04644120Phase 1
- Anakinra in the Management of COVID-19 InfectionCompletedNCT04643678Phase 2/3
- Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)Status unknownNCT04639375Phase 4
- Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 EraStatus unknownNCT04636021
- Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19CompletedNCT04635943Phase 2
- Use of Angiotensin-(1-7) in COVID-19CompletedNCT04633772Phase 1/2
- Intravenous Zotatifin in Adults With Mild or Moderate COVID-19CompletedNCT04632381Phase 1
- Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 SubjectsCompletedNCT04629703Phase 3
- Prevalence and Risk Factors of COVID-19 in the Upper Silesian AgglomerationStatus unknownNCT04627623
- Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) InfectionStatus unknownNCT04627233Phase 1
- Exercise Influence on COVID-19Status unknownNCT04624048
- Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient SettingCompletedNCT04621461Phase 4
- Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19CompletedNCT04619368
- Nasal Photodisinfection COVID-19 Proof of Concept StudyCompletedNCT04615936Not applicable
- A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, IllinoisCompletedNCT04611230
- Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)Status unknownNCT04610567Phase 1/2
- Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaTerminatedNCT04609865Phase 3
- Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019CompletedNCT04609774
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedNCT04606563Phase 3
- A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19WithdrawnNCT04605926Phase 3
- Perceived Stress Among ICU Medical Staff During COVID-19 CrisisCompletedNCT04604769
- Northern Colorado COVID-19 BiobankCompletedNCT04603677
- How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample)CompletedNCT04602312Not applicable
- Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension StudyCompletedNCT04602260
- Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath CondensateCompletedNCT04598620
- Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19CompletedNCT04598581Not applicable
- SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in FloridaCompletedNCT04596579
- Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 PatientsStatus unknownNCT04594330Phase 2
- Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)WithdrawnNCT04590274Phase 1
- COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-CCompletedNCT04588363
- The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and OlderStatus unknownNCT04587219Phase 2
- A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United KingdomCompletedNCT04583995Phase 3
- ImmuneSense™ COVID-19 StudyCompletedNCT04583982
- Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's PatientsStatus unknownNCT04583566
- Inflammatory Signal Inhibitors for COVID-19 (MATIS)CompletedNCT04581954Phase 1/2
- Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or LymphopeniaCompletedNCT04578210Phase 1/2
- T Cells Response to SARS COV 2 PeptidesStatus unknownNCT04573348
- Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) PatientsStatus unknownNCT04572360Not applicable
- Predicting Favorable Outcomes in Hospitalized Covid-19 PatientsCompletedNCT04570488